Gene therapy to treat cardiovascular disease.
作者信息
Wolfram Julie A, Donahue J Kevin
机构信息
Department of Medicine, MetroHealth Campus of Case Western Reserve University, Cleveland, OH.
出版信息
J Am Heart Assoc. 2013 Aug 20;2(4):e000119. doi: 10.1161/JAHA.113.000119.
Abstract
摘要
相似文献
1
Gene therapy to treat cardiovascular disease.用于治疗心血管疾病的基因疗法。
J Am Heart Assoc. 2013 Aug 20;2(4):e000119. doi: 10.1161/JAHA.113.000119.
2
Site-specific gene therapy for cardiovascular disease.心血管疾病的位点特异性基因治疗。
Curr Opin Drug Discov Devel. 2010 Mar;13(2):203-13.
3
Gene therapy for cardiovascular disease.心血管疾病的基因治疗
Curr Opin Pharmacol. 2001 Apr;1(2):197-202. doi: 10.1016/s1471-4892(01)00027-3.
4
Gene therapy approaches to cardiovascular disease.心血管疾病的基因治疗方法。
Methods Mol Med. 2005;112:15-35. doi: 10.1385/1-59259-879-x:015.
5
Novel vectors for in vivo gene delivery to vascular tissue.用于体内基因传递至血管组织的新型载体。
Expert Opin Biol Ther. 2007 Jun;7(6):809-21. doi: 10.1517/14712598.7.6.809.
6
Method of gene delivery in large animal models of cardiovascular diseases.心血管疾病大型动物模型中的基因递送方法。
Methods Mol Biol. 2011;709:355-67. doi: 10.1007/978-1-61737-982-6_23.
7
Gene therapy in cardiovascular surgery.
Surg Today. 1998;28(2):125-8. doi: 10.1007/s005950050092.
8
Ten steps to gene therapy for cardiovascular diseases.
J Lab Clin Med. 1998 Aug;132(2):104-11. doi: 10.1016/s0022-2143(98)90005-1.
9
The emerging role of gene therapy in the treatment of cardiovascular diseases.基因治疗在心血管疾病治疗中的新兴作用。
Crit Rev Clin Lab Sci. 2003 Oct;40(5):499-545.
10
Gene therapy in the cardiovascular system: an update.心血管系统中的基因治疗：最新进展
Cardiovasc Res. 1999 Dec;44(3):498-506. doi: 10.1016/s0008-6363(99)00259-x.
引用本文的文献
1
Gene Therapy for Cardiac Arrhythmias: Mechanisms, Modalities and Therapeutic Applications.心律失常的基因治疗：机制、方式及治疗应用
Med Sci (Basel). 2025 Jul 30;13(3):102. doi: 10.3390/medsci13030102.
2
Cell Reprogramming, Transdifferentiation, and Dedifferentiation Approaches for Heart Repair.用于心脏修复的细胞重编程、转分化和去分化方法。
Int J Mol Sci. 2025 Mar 27;26(7):3063. doi: 10.3390/ijms26073063.
3
Tissue engineering with targeted delivery of nanotized S-nitrosyl mutant of NEMO ameliorates myocardial infarction.靶向递送纳米化NEMO S-亚硝基化突变体的组织工程改善心肌梗死。
Nanomedicine (Lond). 2025 May;20(10):1085-1099. doi: 10.1080/17435889.2025.2491989. Epub 2025 Apr 16.
4
Enhancing Cardiomyocyte Purity through Lactate-Based Metabolic Selection.通过基于乳酸的代谢选择提高心肌细胞纯度。
Tissue Eng Regen Med. 2025 Feb;22(2):249-260. doi: 10.1007/s13770-024-00696-4. Epub 2025 Jan 17.
5
Assessment of adeno-associated virus purity by capillary electrophoresis-based western.基于毛细管电泳的蛋白质免疫印迹法评估腺相关病毒的纯度
Mol Ther Methods Clin Dev. 2024 Aug 14;32(3):101321. doi: 10.1016/j.omtm.2024.101321. eCollection 2024 Sep 12.
6
Cardiac gene delivery using ultrasound: State of the field.利用超声进行心脏基因递送：该领域现状
Mol Ther Methods Clin Dev. 2024 Jun 4;32(3):101277. doi: 10.1016/j.omtm.2024.101277. eCollection 2024 Sep 12.
7
Cell-Specific mRNA Therapeutics for Cardiovascular Diseases and Regeneration.用于心血管疾病和再生的细胞特异性mRNA疗法
J Cardiovasc Dev Dis. 2024 Jan 26;11(2):38. doi: 10.3390/jcdd11020038.
8
Current Landscape of Gene Therapy for the Treatment of Cardiovascular Disorders.心血管疾病基因治疗的现状。
Curr Gene Ther. 2024;24(5):356-376. doi: 10.2174/0115665232268840231222035423.
9
Modern medical services, a double-edged sword manages symptoms, but accumulates genetic background of cardiovascular diseases: A cross populational analysis of 217 countries.现代医疗服务是一把双刃剑，它能控制症状，但会累积心血管疾病的遗传背景：一项对217个国家的跨人群分析。
Health Sci Rep. 2024 Jan 22;7(1):e1828. doi: 10.1002/hsr2.1828. eCollection 2024 Jan.
10
Three-dimensional heart extracellular matrix enhances chemically induced direct cardiac reprogramming.三维心脏细胞外基质增强化学诱导的心脏直接重编程。
Sci Adv. 2022 Dec 14;8(50):eabn5768. doi: 10.1126/sciadv.abn5768.
本文引用的文献
1
Gene therapy for cardiovascular disease mediated by ultrasound and microbubbles.超声与微泡介导的心血管疾病基因治疗
Cardiovasc Ultrasound. 2013 Apr 17;11:11. doi: 10.1186/1476-7120-11-11.
2
Janus-like role of fibroblast growth factor 2 in arteriosclerotic coronary artery disease: atherogenesis and angiogenesis.成纤维细胞生长因子 2 在动脉粥样硬化性冠状动脉疾病中的双面作用：动脉粥样硬化形成和血管生成。
Atherosclerosis. 2013 Jul;229(1):10-7. doi: 10.1016/j.atherosclerosis.2013.03.013. Epub 2013 Mar 26.
3
An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure.一项评价非病毒基质细胞衍生因子-1 质粒给药治疗有症状缺血性心力衰竭安全性的开放性标签剂量递增研究。
Circ Res. 2013 Mar 1;112(5):816-25. doi: 10.1161/CIRCRESAHA.111.300440. Epub 2013 Feb 21.
4
Noncanonical EF-hand motif strategically delays Ca2+ buffering to enhance cardiac performance.非典型 EF 手基序策略性地延迟 Ca2+缓冲以增强心脏功能。
Nat Med. 2013 Mar;19(3):305-12. doi: 10.1038/nm.3079. Epub 2013 Feb 10.
5
HCN2/SkM1 gene transfer into canine left bundle branch induces stable, autonomically responsive biological pacing at physiological heart rates.将 HCN2/SkM1 基因转染至犬左侧束支可在生理心率下诱导稳定、自主响应的生物起搏。
J Am Coll Cardiol. 2013 Mar 19;61(11):1192-201. doi: 10.1016/j.jacc.2012.12.031. Epub 2013 Feb 6.
6
Flushing out antibodies to make AAV gene therapy available to more patients.清除抗体以使更多患者能够接受腺相关病毒基因疗法。
Mol Ther. 2013 Feb;21(2):269-71. doi: 10.1038/mt.2013.5.
7
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association.执行摘要：《2013年心脏病和中风统计数据更新：美国心脏协会报告》
Circulation. 2013 Jan 1;127(1):143-52. doi: 10.1161/CIR.0b013e318282ab8f.
8
Minimizing the inhibitory effect of neutralizing antibody for efficient gene expression in the liver with adeno-associated virus 8 vectors.最小化中和抗体对腺相关病毒 8 载体在肝脏中高效基因表达的抑制作用。
Mol Ther. 2013 Feb;21(2):318-23. doi: 10.1038/mt.2012.258. Epub 2012 Dec 18.
9
Heart disease and stroke statistics--2013 update: a report from the American Heart Association.《2013年心脏病和中风统计数据更新：美国心脏协会报告》
Circulation. 2013 Jan 1;127(1):e6-e245. doi: 10.1161/CIR.0b013e31828124ad. Epub 2012 Dec 12.
10
Connexin43 gene transfer reduces ventricular tachycardia susceptibility after myocardial infarction.缝隙连接蛋白 43 基因转染减少心肌梗死后室性心动过速易感性。
J Am Coll Cardiol. 2012 Sep 18;60(12):1103-10. doi: 10.1016/j.jacc.2012.04.042. Epub 2012 Aug 8.
Zotero 插件